http://archive.fast-edgar.com/20260713/A5Z2W22CD222U2Z2222B2WZLL4VQR22S2282
Filed on: July 13, 2026
http://archive.fast-edgar.com/20260713/ALZH822CZ22HG2Z2222G22Z99R8TZZ2I8282
Filed on: July 13, 2026
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying prospectus, prospectus supplement and underlying supplement do not constitute an offer to sell these securities, and we are not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.
Filed Pursuant to Rule 424(b)(2)
Registration No. 333-287303
Subject to Completion. Dated... (continue reading...)
The information in this preliminary Pricing Supplement is not complete and may be changed. This preliminary Pricing Supplement and the accompanying Underlying Supplement, Prospectus Supplement and Prospectus are not an offer to sell these securities and we are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES... (continue reading...)
More SEC Filings
View Older Stories-
Form D/A USEDC 2026 Drilling Fund
-
Form D Series 18-5, a series
-
Form 425 Axalta Coating Systems Filed by: AKZO NOBEL NV
-
Form 144 KB HOME Filed by: McGibney Robert V.
-
Form 8-K HINES GLOBAL INCOME TRUS For: Jun 23
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 487 FT 13099
-
Form 487 FT 13167
-
Form 10-Q Jubilant Flame Internati For: May 31
-
Form 487 FT 13166
-
Form 497 Rayliant Funds Trust
-
Form 424B2 UBS AG
-
Form 13F-HR Echo45 Advisors LLC For: Jun 30
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form POSASR Esperion Therapeutics,
-
Form D AlphaKeys ExodusPoint
-
Form D Dendrion Innoblative 1,
-
Form POS AM Esperion Therapeutics,
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 424B2 MORGAN STANLEY
-
Form POS AM Esperion Therapeutics,
-
Form POS462B Esperion Therapeutics,
-
Form 4 Fundrise Income Real For: Jul 10 Filed by: Starr Gayle P
-
Form 4/A H2O AMERICA For: Jul 07 Filed by: ATLAS Infrastructure Partners (UK) Ltd.
-
Form 424B2 UBS AG
-
Form D FCP Venture X QP LLC,
-
Form 497 Tidal Trust III
-
Form D Series 18-4, a series
-
Form 497K EA Series Trust
-
Form POS AM Esperion Therapeutics,
-
Form F-6EF Amundi S.A./ADR Filed by: BANK OF NEW YORK / ADR DIVISION
-
Form 4 Texas Pacific Land Corp For: Jul 10 Filed by: HORIZON KINETICS ASSET MANAGEMENT LLC
-
Form POS AM Esperion Therapeutics,
-
Form 13F-HR DAVENPORT & Co LLC For: Jun 30
-
Form 6-K Mint Inc Ltd For: Jul 13
-
Form 424B2 UBS AG
-
Form 424B2 MORGAN STANLEY
-
Form D/A Institutional Drilling
-
Form POS AM Esperion Therapeutics,
-
Form N-PX Lindsell Train Ltd For: Jun 30
-
Form 497 EA Series Trust
-
Form CERT Shell Finance US Inc.
-
Form 424B2 MORGAN STANLEY
-
Form N-PX Intelligent Financial For: Jun 30
-
Form POS AM Esperion Therapeutics,
-
Form CERT Shell plc
-
Form FWP GOLDMAN SACHS GROUP INC Filed by: GOLDMAN SACHS GROUP INC
-
Form FWP GS Finance Corp. Filed by: GS Finance Corp.
-
Form 424B2 UBS AG
-
Form D MDHGEB5 LLC
